Magnetic nanoparticle-based immunosensors and aptasensors for mycotoxin detection in foodstuffs: An update.

Mycotoxin contamination of food crops is a global challenge due to their unpredictable occurrence and severe adverse health effects on humans. Therefore, it is of great importance to develop effective tools to prevent the accumulation of mycotoxins through the food chain. The use of magnetic nanoparticle (MNP)-assisted biosensors for detecting mycotoxin in complex foodstuffs has garnered great interest due to the significantly enhanced sensitivity and accuracy. Within such a context, this review includes the fundamentals and recent advances (2020-2023) in the area of mycotoxin monitoring in food matrices using MNP-based aptasensors and immunosensors. In this review, we start by providing a comprehensive introduction to the design of immunosensors (natural antibody or nanobody, random or site-oriented immobilization) and aptasensors (techniques for aptamer selection, characterization, and truncation). Meanwhile, special attention is paid to the multifunctionalities of MNPs (recoverable adsorbent, versatile carrier, and signal indicator) in preparing mycotoxin-specific biosensors. Further, the contribution of MNPs to the multiplexing determination of various mycotoxins is summarized. Finally, challenges and future perspectives for the practical applications of MNP-assisted biosensors are also discussed. The progress and updates of MNP-based biosensors shown in this review are expected to offer readers valuable insights about the design of MNP-based tools for the effective detection of mycotoxins in practical applications.

Luminescence Lifetime Imaging Based on Lanthanide Nanoparticles.

Luminescence lifetime imaging has exhibited significant advantages over traditional optical imaging in terms of precise quantification detection because of the intrinsic stability of luminescence lifetimes. Recently, great emphasis has been put on the exploration of lanthanide-doped nanoparticles (LnNPs) with long-lived luminescence. The long luminescence lifetime of LnNPs not only makes it easier to filter out background signals during imaging, but also provides a wide range of tunable lifetime. Here, we introduce the luminescence mechanisms of LnNPs, the key strategies for luminescence lifetime modulation, data acquisition methods, and several cutting-edge applications in lifetime imaging systems. Then we describe several prospects to inspire efforts for improving technologies and extending applications of luminescence lifetime imaging.

Direct measurement of beta-agonists in swine hair extract in multiplexed mode by surface-enhanced Raman spectroscopy and microfluidic paper.

Bare gold nanoparticles selectively enhance the Raman signal of beta-agnonists in swine hair extract at 780 nm, which enables analysis of beta-agonists in swine hair extract without chemical labeling, purification, or separation. The analysis is multiplexable and the LOD of beta-agonists is around ng/mL in the assistance of microfluidic paper.

Aggregation-induced emission nanoparticles facilitating multicolor lateral flow immunoassay for rapid and simultaneous detection of aflatoxin B1 and zearalenone.

Herein we developed a multicolor lateral flow immunoassay (LFIA) test strip for rapid and simultaneous quantitative detection of aflatoxin B1 (AFB1) and zearalenone (ZEN). Three differently colored aggregation-induced emission nanoparticles (AIENPs) were designed as LFIA signal tags, with red and green AIENPs for targeting AFB1 and ZEN at the test line, and yellow AIENPs for indicating the validity of the test strip at the control (C) line. After surface functionalization with antibodies, the developed AIENP-based multicolor LFIA allows simultaneous and accurate quantification of AFB1 and ZEN using an independent C-line assisted ratiometric signal output strategy. The detection limits of AFB1 and ZEN were 6.12 and 26 pg/mL, respectively. The potential of this method for real-world applications was well demonstrated in corn and wheat. Overall, this multicolor LFIA shows great potential for field screening of multiple mycotoxins and can be extended to rapid and simultaneous monitoring of other small molecule targets.

Development and optimization of a frequency mixing sensor for adjacent samples quantitative detection on a lateral flow assay.

Frequency-mixing technology has been widely used to precisely identify magnetic nanoparticles in applications of quantitative biomedical detection in recent years. Examples include immune adsorption, lateral flow assays (LFAs), and biomagnetic imaging. However, the signals of magnetic response generated by adjacent magnetic samples interfere with each other owing to the small spacing between them in applications involving multi-sample detection (such as the LFA and multiplexing detection). Such signal interference prevents the biosensor from obtaining characteristic peaks related to the concentration of adjacent biomarkers from the magnetic response signals. Mathematical and physical models of the structure of sensors based on frequency-mixing techniques were developed. The theoretical model was verified and its key parameters were optimized by using simulations. A new frequency-mixing magnetic sensor structure was then designed and developed based on the model, and the key technical problem of signal crosstalk between adjacent samples was structurally solved. Finally, standard cards with stable magnetic properties were used to evaluate the performance of the sensor, and strips of the gastrin-17 (G-17) LFA were used to evaluate its potential for use in clinical applications. The results show that the minimum spacing between samples required by the optimized sensor to accurately identify them was only about 4-5 mm, and the minimum detectable concentration of G-17 was 11 pg mL-1 . This is a significant reduction in the required spacing between samples for multiplexing detection. The optimized sensor also has the potential for use in multi-channel synchronous signal acquisition, and can be used to detect synchronous magnetic signals in vivo.

Dual-color quantum dots nanobeads based suspension microarray for simultaneous detection of dual prostate specific antigens.

Featured with high multiplexibility, suspension microarray technology usually involves the conjugation of second-antibody with organic dye based fluorescent proteins, which are inherently unsuitable for multicolor signaling under single wavelength excitation. In addition, application of single QDs-based fluorescent reporter in suspension microarray is dramatically hampered since its preparation often suffers from poor reproducibility and stability. Herein, a novel suspension microarray system based on dual color quantum dots (QDs) nanobead as fluorescence label was developed for simultaneous detection of prostate specific antigen (PSA) biomarkers. When both antigens are present in sera sample, free (f)-PSA antibody-conjugated green and complexed (c)-PSA antibody-conjugated red QDs nanobeads would be both specifically absorbed onto the surface of total PSA antibody-conjugated magnetic beads, leading to the formation of magnetic fluorescent hybrid that can be purified from the mixture by an external magnet prior to flow cytometry analysis. The proposed method demonstrates simultaneous detection ability for f- and c- PSA antigen assay with high detection sensitivity that is comparable to clinical approaches including ELISA and chemiluminescence assay. Furthermore, result of clinical application of the proposed method is consistency with clinical data, demonstrating its potential in suspension microarray for accurate prostate cancer diagnosis.

Flow cytometry-based multiplexing antibody detection for diagnosis of African swine fever virus.

African swine fever (ASF) is an infectious disease that has a mortality rate of nearly 100% in domestic pigs. To date, no vaccine or effective treatment for ASF is available, necessitating the development of an accurate and sensitive diagnostic method to monitor ASF virus (ASFV) antibodies for prevention and control. Herein, a reliable and sensitive suspension microarray technology-based multiplexing method was developed for ASFV antibody detection using recombinant CD2v, p30, p54, and p22 antigen protein coated size-encoded microbeads as probes to capture the target antibody. Compared to commercial ELISA kits, the newly developed method showed a 16-fold improvement in detection sensitivity. Differential diagnosis of CD2v-unpressed low-virulence mutant (genotype II) and wild-type ASFV (genotype II) was readily achieved by fluorescence signal analysis of the CD2v-coated probe in the microbead mixture solution. In addition, the real serum assay revealed a 97% consistency rate between the novel method and commercial ELISA kits, demonstrating excellent potential for ASF epidemic surveillance and control.

A novel gold nanoparticles decorated magnetic microbead-based molecular beacon for DNA multiplexing detection by flow cytometry.

Gold nanoparticles-based molecular beacon (Au NPs-MB), due to its extraordinary highly-quenching efficiency for fluorophores, has been extensively investigated and widely used for bioimaging and bioassay. However, apart from irreversible aggregation during the "aging" step, the preparation of Au NPs-MB often suffers from relatively poor salt stability, limiting its further in vivo application. Herein, Au NPs decorated magnetic microbeads was developed to construct a novel magnetic MB for DNA assay, which not only totally solved the aggregation problem of Au NPs, but also exhibited robust stability in buffer solution. Most importantly, the fluorescence signal of each microbeads could be collected individually, realizing single microbeads-based DNA imaging, and the detection limit for target DNA could reach 0.1 nM with the detection range of 0.2-20 nM. More importantly, because the magnetic microbeads with three sizes could be readily distinguished by flow cytometry, the employed three types of hairpin DNA probes can be labelled with the same dye FITC without fluorescence cross-interference. Therefore, multiplexing detection of tumor-suppressor genes (p16, p21 and p53) could be readily realized by using size-encoded magnetic microbeads pre-functionalized with corresponding probe DNA illustrating the potential of this method in multiplexing bioassay applications.

Poly-adenine-mediated spherical nucleic acids for strand displacement-based DNA/RNA detection.

DNA-gold nanoparticles (AuNPs) conjugate is one of the most versatile bionanomaterials for biomedical and clinical diagnosis. However, to finely tune the hybridization ability and precisely control the orientation and conformation of surface-tethered oligonucleotides on AuNPs remains a hurdle. In this work, we developed a poly adenine-mediated spherical nucleic acid (polyA-mediated SNA) strategy by assembling di-block DNA probes on gold nanoparticles (AuNPs) to spatially control interdistance and hybridization ability of oligonucleotides on AuNPs. By modulating length of poly A bound on the SNA with different degrees of constructing, we presented significant improved biosensing performance including high hybridization efficiency, and expanded dynamic range of analytes with more sensitive detection limit. Furthermore, this polyA design could facilitate the programmable detection for DNA in serum environment and simultaneous multicolor detection of three different microRNAs associated with pancreatic carcinoma. The demonstration of the link between modulation of SNA assembly strategy and biodetection capability will increase the development of high performance diagnostic tools for translational biomedicine.

Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels.

In this study, we developed a multiplex immunoassay system that combines the suspension and planar microarray formats within a single layer of polydimethylsiloxane (PDMS) using soft lithography technology. The suspension format was based on the target proteins forming a sandwich structure between the magnetic beads and the quantum dot (QD) probes through specific antibody-antigen interactions. The planar microarray format was produced by fabricating an array of micro-wells in PDMS. Each micro-well was designed to trap a single microbead and eventually generated a microbead array within the PDMS chamber. The resultant bead-based on-chip assay could be used for simultaneously detecting three lung cancer biomarkers-carcinoembryonic antigen (CEA), fragments of cytokeratin 19 (CYFRA21-1) and neuron-specific enolase (NSE)-in 10 µl of human serum, with a wide linear dynamic range (1.03-111 ng/mL for CEA and CYFRA21-1; 9.26-1000 ng/ml for NSE) and a low detection limit (CEA: 0.19 ng/ml; CYFRA21-1: 0.97 ng/ml; NSE: 0.37 ng/ml; S/N=3). Our micro-well chip does not require complex e-beam lithography or the reactive ion etching process as with existing micro-well systems, which rely on expensive focused ion beam (FIB) milling or optical fiber bundles. Furthermore, the current approach is easy to operate without extra driving equipment such as pumps, and can make parallel detection for multiplexing with rapid binding kinetics, small reagent consumption and low cost. This work has demonstrated the importance of the successful application of on-chip multiplexing sandwich assays for the detection of biomarker proteins.

The evolution of nanopore sequencing.

The "$1000 Genome" project has been drawing increasing attention since its launch a decade ago. Nanopore sequencing, the third-generation, is believed to be one of the most promising sequencing technologies to reach four gold standards set for the "$1000 Genome" while the second-generation sequencing technologies are bringing about a revolution in life sciences, particularly in genome sequencing-based personalized medicine. Both of protein and solid-state nanopores have been extensively investigated for a series of issues, from detection of ionic current blockage to field-effect-transistor (FET) sensors. A newly released protein nanopore sequencer has shown encouraging potential that nanopore sequencing will ultimately fulfill the gold standards. In this review, we address advances, challenges, and possible solutions of nanopore sequencing according to these standards.